Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:572-575
Published online before print February 12, 2009, doi: 10.1161/CIRCRESAHA.108.193250
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/5/572    most recent
CIRCRESAHA.108.193250v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, C.
Right arrow Articles by Kukreja, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, C.
Right arrow Articles by Kukreja, R. C.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Ischemic biology - basic studies
Right arrow Physiological and pathological control of gene expression
(Circulation Research. 2009;104:572.)
© 2009 American Heart Association, Inc.


Report

A Novel Role of MicroRNA in Late Preconditioning

Upregulation of Endothelial Nitric Oxide Synthase and Heat Shock Protein 70

Chang Yin*, Fadi N. Salloum*, Rakesh C. Kukreja

From the Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond.

Correspondence to Rakesh C. Kukreja, PhD, Professor of Medicine, Physiology, Biochemistry and Emergency Medicine, Eric Lipman Distinguished Chair of Cardiology, Division of Cardiology, Box 980281, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298-0281. E-mail rakesh{at}vcu.edu

MicroRNAs (miRNAs) are noncoding RNAs of 18 to 24 nucleotides that are involved in posttranscriptional regulation of protein expression. Their role in ischemic preconditioning (IPC) is currently unknown. We hypothesized that miRNAs induced after IPC in the heart may create a preconditioned phenotype through upregulating proteins including endothelial nitric oxide synthase (eNOS)/inducible nitric oxide synthase (iNOS) and heat shock protein (HSP)70, which are implicated in the late-phase protection of IPC. miRNAs were extracted from hearts of ICR mice following IPC. The purified miRNAs were injected in vivo into the left ventricular wall of mice, and, 48 hours later, the hearts were subjected to regional ischemia/reperfusion injury by left anterior descending artery ligation for 30 minutes followed by reperfusion for 24 hour. IPC caused no changes in miRNA-23b and miRNA-483 whereas miRNA-1, miRNA-21and miRNA-24 were significantly increased. The IPC-miRNA treatment caused an increase in eNOS mRNA and protein, whereas iNOS was not changed. HSF-1 (heat shock transcription factor 1) and HSP70 were also increased with IPC-miRNA treatment versus control. Moreover, injection of IPC-miRNA protected the hearts against ischemia/reperfusion injury, as shown by a reduction of infarct size as compared with saline or non-IPC miRNA-treated control. We conclude that IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1.


Key Words: miRNA • eNOS • HSP70 • ischemia/reperfusion • preconditioning